{"filing":{"accession_number":"0001213900-26-069611","cik":"0001711754","ticker":"INMB","company_name":"Inmune Bio, Inc.","form":"8-K","filing_date":"2026-06-17","report_date":null,"primary_document":"ea0295129-8k_inmune.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026069611/ea0295129-8k_inmune.htm"},"events":[{"id":11507,"run_id":10104,"accession_number":"0001213900-26-069611","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Stockholders approved three proposals at the Annual Meeting held on June 16, 2026: election of five directors (David Moss, J. Kelly Ganjei, Tim Schroeder, Scott Juda, and Marcia Allen), ratification of CBIZ CPAs P.C. as independent auditors, and approval of the Third Amended and Restated 2021 Stock Incentive Plan with increased reserved shares and an evergreen provision.","company_name":"Inmune Bio, Inc.","ticker":"INMB","filing_date":"2026-06-17","submitted_at":null,"items":[{"id":8107,"accession_number":"0001213900-26-069611","item_number":"5.02","item_title":"Departure of Directors or Certain Officers;","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on stockholder approval of the Third Amended and Restated 2021 Stock Incentive Plan, which increased reserved shares from 6.5 million to 9.16 million and implemented an evergreen provision for automatic annual increases through 2031. This is a material compensatory arrangement affecting equity grants and executive compensation, approved at the Annual Meeting on June 16, 2026.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T20:02:11.810832+00:00","company_name":"","ticker":null,"filing_date":""},{"id":8108,"accession_number":"0001213900-26-069611","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of an Annual Meeting of stockholders. The filing presents voting results for three proposals: (1) election of five directors (David Moss, J. Kelly Ganjei, Tim Schroeder, Scott Juda, and Marcia Allen), (2) ratification of CBIZ CPAs P.C. as independent auditors, and (3) approval of the Third Amended and Restated 2021 Stock Incentive Plan. All three proposals passed with clear majorities. This is material as it confirms the composition of the board and auditor appointment for the fiscal year.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T20:02:11.810832+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8107,"accession_number":"0001213900-26-069611","item_number":"5.02","item_title":"Departure of Directors or Certain Officers;","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on stockholder approval of the Third Amended and Restated 2021 Stock Incentive Plan, which increased reserved shares from 6.5 million to 9.16 million and implemented an evergreen provision for automatic annual increases through 2031. This is a material compensatory arrangement affecting equity grants and executive compensation, approved at the Annual Meeting on June 16, 2026.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T20:02:11.810832+00:00","company_name":"Inmune Bio, Inc.","ticker":"INMB","filing_date":"2026-06-17"},{"id":8108,"accession_number":"0001213900-26-069611","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of an Annual Meeting of stockholders. The filing presents voting results for three proposals: (1) election of five directors (David Moss, J. Kelly Ganjei, Tim Schroeder, Scott Juda, and Marcia Allen), (2) ratification of CBIZ CPAs P.C. as independent auditors, and (3) approval of the Third Amended and Restated 2021 Stock Incentive Plan. All three proposals passed with clear majorities. This is material as it confirms the composition of the board and auditor appointment for the fiscal year.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T20:02:11.810832+00:00","company_name":"Inmune Bio, Inc.","ticker":"INMB","filing_date":"2026-06-17"}]}